TipRanks
AbbVie (ABBV)
NYSE:ABBV
US Market
ABBV
AbbVie
RESEARCH TOOLSreports
Want to see ABBV full AI Analyst Report?

AbbVie (ABBV) Stock News & Sentiment

24,289 Followers
Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look
Premium
Market News
Looking for Dividend Aristocrats? These 3 Healthcare Stocks Deserve a Closer Look
55m ago
JNJ
MDT
AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study
Premium
Company Announcements
AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study
23h ago
ABBV
3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List
Premium
Market News
3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List
2d ago
ABT
JNJ
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
Premium
Company Announcements
AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors
7d ago
ABBV
AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence
Premium
Company Announcements
AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence
9d ago
ABBV
AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline
Premium
Company Announcements
AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline
9d ago
ABBV
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
Premium
Ratings
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
11d ago
ABBV
More ABBV News >

ABBV News on the Web

Health Care Select Sector SPDR (XLV) Adds Eli Lilly and JNJ on Oct. 7
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and PepGen Inc. (PEPG)
TipRanks News
Bullish
AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?
Insider Monkey
Neutral
AbbVie, Genmab's Epcoritamab Plus R-CHOP Improves PFS & Cuts Progression Risk In Lymphoma
rttnews
Neutral
AbbVie Joins Federal 340B Rebate Pilot Program Ahead Of 2027 Launch
rttnews
Neutral
AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?
Insider Monkey
Bullish
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
The Motley Fool
Bullish
How to Create a Million-Dollar Stock Portfolio
Zacks
Neutral

News Score - Last 7 Days

Very Positive
ABBV
Sector Average
Media Buzz
This Week33 articles
Weekly Average28 articles
News Sentiment
This Week95%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABBV’s Media Buzz Sentiment?
33 articles about ABBV were published this week. In an average week, 28 articles are published.
    What is ABBV’s weekly average amount of articles?
    In an average week, 28 articles about ABBV are published.
      What is ABBV’s News Sentiment?
      95% of articles about ABBV were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        MCKMcKesson
        ONCBeOne Medicines
        NVSNovartis
        NTRANatera
        Showing the stocks with the most bullish news sentiment over the past week